News: HLS Healius Expects Underlying FY 2024 EBITDA Of A$359 Million - A$369 Million

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 21 (Reuters) - Healius Ltd (HLS) :

    • NOW EXPECTS UNDERLYING FY 2024 EBITDA OF A$359 MILLION - A$369 MILLION
    • VOLUME GROWTH SEEN IN Q1 OF FY 2024 HAS SOFTENED
    • EXPECTS UNDERLYING EBITDA OF A$158 MILLION - A$161 MILLION FOR HY
    • NON-CASH IMPAIRMENT CHARGE OF A$603 MILLION WILL BE MADE TO GOODWILL IN PATHOLOGY DIVISION IN 1H 2024 RESULTS
    • RESPONDING TO SOFTENED VOLUME GROWTH WITH ACCELERATED PLAN TO RESHAPE BUSINESS AND MATCH COSTS TO CURRENT VOLUMES
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
84.5¢
Change
0.005(0.60%)
Mkt cap ! $613.5M
Open High Low Value Volume
83.5¢ 86.5¢ 81.5¢ $3.101M 3.675M

Buyers (Bids)

No. Vol. Price($)
1 9 84.5¢
 

Sellers (Offers)

Price($) Vol. No.
85.0¢ 49196 5
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
HLS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.